Page last updated: 2024-11-06

phentolamine and MS (Multiple Sclerosis)

phentolamine has been researched along with MS (Multiple Sclerosis) in 2 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Using papaverine, papaverine/phentolamine, or prostaglandin E1 (PGE1), intracavernosal pharmacotherapy has been successful in treating erectile dysfunction."3.69Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. ( Chao, R; Clowers, DE, 1994)
"Treatment with phenoxybenzamine was found valuable in patients with multiple sclerosis and poor bladder emptying as well as in patients with lower motor neuron bladder paresis."1.26Alpha-blockers and urethral pressure in neurological patients. ( Nordling, J, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, R1
Clowers, DE1
Nordling, J1

Other Studies

2 other studies available for phentolamine and MS (Multiple Sclerosis)

ArticleYear
Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
    Archives of physical medicine and rehabilitation, 1994, Volume: 75, Issue:3

    Topics: Adult; Alprostadil; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Drug Monitoring; Drug Syne

1994
Alpha-blockers and urethral pressure in neurological patients.
    Urologia internationalis, 1978, Volume: 33, Issue:5

    Topics: Adrenergic alpha-Antagonists; Female; Humans; Male; Multiple Sclerosis; Paralysis; Phenoxybenzamine;

1978